Update on Relapsed/Refractory Mantle Cell Lymphoma | LRF Webinars

The Lymphoma Research Foundation is the nation's largest non-profit organization devoted to funding innovative research and providing people with lymphoma and healthcare professionals with up-to-date information about this type of cancer.
LEARN MORE!
lymphoma.org/
/ lymphomacommunity
/ lymphoma
/ lymphomacommunity

[@23dfmahghd]

When they say for example Acalabrutinib ORR 81% and 40% attaining a CR they mean 40% of the 124 patients or 40% of 81% (100 patients)?

[@davidbuche]

40% or the 124